Loading...
Meplazumab is a monoclonal antibody biosimilar expressed in CHO cells, targeting CD147, Meplazumab is a humanized anti-CD147 antibody that can competitively inhibit the binding of SP and CD147, prevent viruses from invading host cells, and provide a potential target for the development of antiviral drugs.
Biosimilars
Human
Monoclonal
Human
CD147
Human
IgG1 Kappa
Unconjugated
Liquid
ELISA, WB
100 µg
1 mg
Recombinant
> 95%
Purified from cell culture supernatants by Protein A/G chromatography.
0.01 M PBS. pH 7.4.
Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
No
Shipped within 7-12 working days.
Biosimilars
Precio a consultar
Ver másPrecio a consultar
Ver másPrecio a consultar
Ver más